VaxAtlas

Boston, United States Founded: 2008 • Age: 18 yrs
Provides COVID-19 screening and decision-support solutions tailored for employers.
Annual revenue - Latest available
Total funding $1.2M 2 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About VaxAtlas

VaxAtlas is a company based in Boston (United States) founded in 2008 by Judi Korzec. It operates as a B2B. VaxAtlas has raised $1.2 million across 2 funding rounds from investors including NFP Venture. VaxAtlas operates in a competitive market with competitors including PocDoc, Hilab, Enviral Tech, Achiko and CoVerified, among others.

  • Headquarter Boston, United States
  • Founders Judi Korzec
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Vaxatlas, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $1.2 M (USD)

    in 2 rounds

  • Latest Funding Round
    $1 M (USD), Seed

    Mar 19, 2021

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of VaxAtlas

VaxAtlas has successfully raised a total of $1.2M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in VaxAtlas

VaxAtlas has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include NFP Venture.

All
Venture Fund
Investor Description Founded Year Domain Location
Venture capital firm focused on fintech & insurtech sectors
Locked Locked Locked
Premium access

Investor details for VaxAtlas

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by VaxAtlas

Investments
Premium access

Investment portfolio details for VaxAtlas

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - VaxAtlas

Premium access

Detailed financials for VaxAtlas

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Vaxatlas Comparisons

VaxAtlas Primary company
Description
Provides COVID-19 screening and decision-support solutions t...
Location
Boston, United States
Founded Year
2008
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for VaxAtlas

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of VaxAtlas

VaxAtlas operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PocDoc, Hilab, Enviral Tech, Achiko and CoVerified, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of smartphone based rapid testing for major diseases
Locked Locked Locked
Remote monitoring systems and AI-based health diagnostic devices are developed.
Locked Locked Locked
Provider of live lottery draw results and data. It offers live streaming of lottery draws, providing real-time results to users. The platform also maintains a comprehensive historical database of lottery results, allowing users to access past winning numbers. This data is presented in a user-friendly format, facilitating analysis and prediction. The service aims to provide accurate and timely information directly from official sources. It ensures transparency and reliability in presenting lottery outcomes.
Locked Locked Locked
Provider of COVID-19 test tools and solutions for clinicians and patients
Locked Locked Locked
COVID-19 contact and symptoms tracking is enabled via mobile platform.
Locked Locked Locked
Provider of software for health risk assessment and COVID-19 fever screening
Premium access

Detailed competitors of VaxAtlas

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Vaxatlas

Premium access

Complete news archive for VaxAtlas

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about VaxAtlas

VaxAtlas was founded in 2008 and raised its 1st funding round 13 years after it was founded.

VaxAtlas is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.

Judi Korzec is the current CEO of VaxAtlas. They have also founded this company.

VaxAtlas is a funded company, having raised a total of $1.2M across 2 funding rounds to date.

VaxAtlas, based in Boston, focuses on health, public health, screening services, and covid-19 solutions. Provides COVID-19 screening and decision-support solutions tailored for employers. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

VaxAtlas's top competitors include PocDoc, Hilab and Enviral Tech.

VaxAtlas has 1 investor. Key investors include NFP Venture.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available